Reports for the Central Nervous System industry in Zones

Central Nervous System

Central Nervous System

View Report: Research and Experts Market Report: OpportunityAnalyzer: Osteoarthritis - Opportunity Analysis and Forecasts to 2024

OpportunityAnalyzer: Osteoarthritis - Opportunity Analysis and Forecasts to 2024

Global
Market Report
2016-06-27
Report 05IC-GDHC043POA has a star rating of 3.5 out of 5
Osteoarthritis (OA) is a slowly progressive joint disease that is typically seen in middle-aged to elderly people. The disease is caused by the breakdown of the joint cartilage due to mechanical stress or biochemical alterations, which causes the bone...
$10,995.00

View Report: Research and Experts Market Report: PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

Global
Market Report
2016-09-01
Report 05IC-GDHC125PIDR has a star rating of 3.9 out of 5
Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels of inattention, impulsivity, and hyperactivity, either alone or in combination that have a significant social impact through disruptions at school, work, home, and in...
$10,995.00

View Report: Research and Experts Market Report: PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

PharmaPoint: Major Depressive Disorder - Global Drug Forecast and Market Assessment to 2025

Global
Market Report
2016-10-05
Report 05IC-GDHC126PIDR has a star rating of 4.0 out of 5
Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. It is characterized by single or recurrent major depressive episodes (MDEs), where patients can typically experience periods of depressed mood, loss of energy, abnor...
$10,995.00

View Report: Research and Experts Market Report: PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2026

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2026

Global
Market Report
2017-08-10
Report 05IC-GDHC153PIDR has a star rating of 4.3 out of 5
Migraine is a complex neurological condition, characterized by frequent headaches that can last between four and 72 hours. The pain is often unilateral and pulsating in nature, which can often be worsened by physical activity. In most cases, migraine...
$10,995.00

View Report: Research and Experts Market Report: PharmaPoint: Alzheimer

PharmaPoint: Alzheimer's Disease - Global Drug Forecast and Market Analysis to 2026

Global
Market Report
2017-09-15
Report 05IC-GDHC149PIDR has a star rating of 4.3 out of 5
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that is characterized by impaired memory and thinking (known as dementia), and functional decline. With a rapidly accelerating worldwide prevalence, there is a growing societal pressure...
$10,995.00

View Report: Research and Experts Market Report: PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2026

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis to 2026

Global
Market Report
2017-10-09
Report 05IC-GDHC154PIDR has a star rating of 4.2 out of 5
Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. Seizures result from abnormal electrical discharges in the brain and vary in their manifestations, from the brief staring spells that are characteristic of absen...
$10,995.00

View Report: Research and Experts Market Report: Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat...

Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes

Global
Market Report
2016-08-01
Report 05ID-GBIHC356MR has a star rating of 3.6 out of 5
Pain, and in particular chronic pain, is a significant global health issue. While pain is not considered a disease in its own right, there is a growing body of evidence that substantiates chronic pain as a disease, rather than just as a symptom of a prima...
$6,995.00

View Report: Research and Experts Market Report: Frontier Pharma: Alzheimer

Frontier Pharma: Alzheimer's Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression

Global
Market Report
2017-05-01
Report 05ID-GBIHC441MR has a star rating of 4.2 out of 5
Alzheimer’s disease (AD), the most common form of dementia, is a progressive, neurodegenerative and currently incurable disease characterized by loss of memory and other mental abilities. It has a devastating impact on independence and quality of...
$6,995.00

View Report: Research and Experts Market Report: Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline...

Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD

Global
Market Report
2017-11-01
Report 05ID-GBIHC460MR has a star rating of 4.2 out of 5
Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, but this diverse therapy area remains largely untreatable with current therapies. Neurodegenerative diseases are characterized by neuronal death within the brain...
$6,995.00

View Report: Research and Experts Market Report: Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle...

Global Pain Therapeutics Market to 2023 - Innovative New Products to Address Unmet Need within Chronic Pain and Migraine, and Tackle Opioid Abuse

Global
Market Report
2017-06-01
Report 05ID-GBIHC443MR has a star rating of 4.2 out of 5
The pain therapeutics market covers the drugs used for the relief of acute and chronic pain. This market has long been characterized by high levels of generic revenue, derived largely from opioids, which see high levels of usage worldwide and particularly...
$4,995.00

Page created and rendered - Cache updated [8.4951029s]